NREF Announces First Quarter 2025 Results, Provides Second Quarter 2025 Guidance
PR Newswire
DALLAS, May 1, 2025
DALLAS, May 1, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended March 31, 2025.
NREF reported net income attributable to common stockholders of $16.5 million, or $0.70 per diluted share(1) , for the three months ended March 31, 2025.
NREF reported cash available for distribution(2) of $10.5 million, or $0.45 per diluted common share(2) , for the three months ended March 31, 2025.
"NREF is pleased to announce another strong quarter, showcasing consistent and resilient earnings across our primary property types. In an environment where banks and traditional lenders are often preoccupied with credit challenges, we remain proactive and committed. Our ability to allocate capital in this challenging credit market allows us to capitalize on market opportunities and deliver long-term value to our shareholders," commented Chief Investment Officer Matthew McGraner.
First Quarter 2025 Highlights
-- Outstanding total portfolio of $1.2 billion, composed of 85 investments3 -- Single-family rental ("SFR"), multifamily, life sciences, specialty manufacturing, self-storage and marinas represent 15.6%, 49.4%, 31.9%, 0.9%, 1.6% and 0.6% of the Company's investment portfolio, respectively -- Weighted-average loan to value ("LTV")4 and debt service coverage ratio ("DSCR") on our senior loans, CMBS, CMBS I/O strips, preferred equity, mezzanine and revolving credit facilities investments are 58.7% and 1.46x3, respectively -- During 1Q 2025, NREF purchased $55.0MM of Preferred Stock -- During the quarter, the Company funded $20.8MM on a loan that pays a monthly coupon of SOFR + 900 bps.
(1) Weighted-average shares outstanding - diluted assumes vesting of all outstanding unvested restricted stock units and the conversion of all redeemable non-controlling interests.
(2) Earnings available for distribution ("EAD") and cash available for distribution ("CAD") are non-GAAP measures. Beginning in the second quarter of 2024, EAD per diluted common share and CAD per diluted common share are based on adjusted weighted average common shares outstanding - diluted. Adjusted weighted average common shares outstanding - diluted is a non-GAAP measure. For a discussion of why we consider these non-GAAP measures useful and reconciliations of these non-GAAP measures, see the "Reconciliations of Non-GAAP Financial Measures" and "Non-GAAP Financial Measures" sections of this release.
(3) As of March 31, 2025; and excluding the common stock investments, the Hudson Montford and Alexander at the District multifamily properties. CMBS B-Pieces reflected on an unconsolidated basis.
(4) Loan to value is generally based on the initial loan amount divided by the as-is appraised value as of the date the loan was originated or by the current principal amount as of the date of the most recent as-is appraised value. For our CMBS B-Pieces, LTV is based on the weighted-average LTV of the underlying loan pool.
(5) Net income attributable to common stockholders in 2Q 2025 is estimated to be between $7.6MM and $9.8MM. See reconciliations below.
Looking Ahead: Second Quarter 2025 Guidance
Earnings Available for Distribution(2)
-- 2Q 2025 EAD per diluted common share guidance is $0.435 at the midpoint Low Mid High -------------- -------------- -------------- June 30, 2025 June 30, 2025 June 30, 2025 -------------- -------------- -------------- Net income $ 13,961 $ 15,175 $ 16,237 Net (income) loss attributable to Series A Preferred stockholders (874) (874) (874) Net (income) loss attributable to Series B Preferred stockholders (5,530) (5,530) (5,530) ---------- ---------- ---------- Net income attributable to common stockholders $ 7,557 $ 8,771 $ 9,833 ========== ========== ========== Adjustments Amortization of stock-based compensation 1,552 1,552 1,552 ---------- ---------- ---------- EAD $ 9,109 $ 10,323 $ 11,385 ========== ========== ========== Weighted average common shares outstanding -- basic 17,810 17,810 17,810 ========== ========== ========== Weighted average common shares outstanding -- diluted 38,056 38,056 38,056 ========== ========== ========== Shares attributable to potential redemption of Series B Preferred (14,164) (14,164) (14,164) ========== ========== ========== Adjusted weighted average common shares outstanding -- diluted (1) 23,892 23,892 23,892 ========== ========== ========== EPS per Weighted Average Share -- diluted $ 0.34 $ 0.38 $ 0.40 ========== ========== ========== EAD per diluted common share (2) $ 0.38 $ 0.43 $ 0.48 ========== ========== ========== EPS Dividend Coverage Ratio 0.68 x 0.76 x 0.80 x EAD Dividend Coverage Ratio (2) 0.76 x 0.86 x 0.96 x
Cash Available for Distribution(2)
-- 2Q 2025 CAD per diluted common share guidance is $0.485 at the midpoint Low Mid High -------------- -------------- -------------- June 30, 2025 June 30, 2025 June 30, 2025 -------------- -------------- -------------- EAD $ 9,109 $ 10,323 $ 11,385 Adjustments Amortization of premiums 2,503 2,503 2,503 Accretion of discounts (2,327) (2,327) (2,327) Amortization and depreciation 1,079 1,079 1,079 ---------- ---------- ---------- CAD $ 10,364 $ 11,578 $ 12,640 ========== ========== ========== Weighted average common shares outstanding -- basic 17,810 17,810 17,810 ========== ========== ========== Weighted average common shares outstanding -- diluted 38,056 38,056 38,056 ========== ========== ========== Shares attributable to potential redemption of Series B Preferred (14,164) (14,164) (14,164) ========== ========== ========== Adjusted weighted average common shares outstanding -- diluted (1) 23,892 23,892 23,892 ========== ========== ========== EPS per Weighted Average Share -- diluted $ 0.34 $ 0.38 $ 0.40 ========== ========== ========== CAD per diluted common share (2) $ 0.43 $ 0.48 $ 0.53 ========== ========== ========== EPS Dividend Coverage Ratio 0.68 x 0.76 x 0.80 x CAD Dividend Coverage Ratio (2) 0.86 x 0.96 x 1.06 x (1) Adjusted weighted average common shares outstanding -- diluted does not include the dilutive effect of the potential redemption of Series B Preferred Stock for common shares. (2) Beginning in the second quarter of 2024, EAD per diluted common share, CAD per diluted common share and the related coverage ratios are based on adjusted weighted average common shares outstanding -- diluted. Adjusted weighted average common shares outstanding -- diluted does not include the dilutive effective of the potential redemption of Series B Preferred Stock for our common shares.
Conference Call Details
The Company is scheduled to host a conference call on Thursday, May 01, 2025, at 11:00 a.m. ET (10:00 a.m. CT), to discuss first quarter 2025 financial results.
The conference call can be accessed live over the phone by dialing 888-660-4430 or +1 646-960-0537 and entering Conference ID 6891136. A live audio webcast of the call will be available online at the Company's website, https://nref.nexpoint.com (under "Resources"). An online replay will be available shortly after the call on the Company's website and continue to be available for 60 days.
A replay of the conference call will also be available through Thursday, May 15, 2025, by dialing 1 800- 770- 2030 or, for international callers, +1 609-800-9099 and entering passcode 6891136.
For additional commentary and portfolio information, please view NREF's earning supplement, which was posted on the Company's website, http://nref.nexpoint.com.
Reconciliations of Non-GAAP Financial Measures
(MORE TO FOLLOW) Dow Jones Newswires
May 01, 2025 08:15 ET (12:15 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.